JP Morgan Chase
EVGN icon

JP Morgan Chase’s Evogene EVGN Stock Holding History

JP Morgan Chase’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-200
Closed -$114 – 7240
2025
Q1 		$114 Sell
200
-3,961
-95% -$5.97K ﹤0.01% 6859
2024
Q4 		$7.78K Buy
4,161
+3,522
+551% +$6.95K ﹤0.01% 6431
2024
Q3 		$1.96K Sell
639
-858
-57% -$3.7K ﹤0.01% 6625
2024
Q2 		$9.74K Sell
1,497
-2,446
-62% -$17.1K ﹤0.01% 6271
2024
Q1 		$29.6K Sell
3,943
-2,516
-39% -$21K ﹤0.01% 6121
2023
Q4 		$54.3K Buy
6,459
+2,933
+83% +$18.4K ﹤0.01% 5971
2023
Q3 		$20.7K Buy
+3,526
New +$30.9K ﹤0.01% 6060
2023
Q2 		– Sell
-7
Closed – – 7032
2023
Q1 		$0 Sell
7
-7
-50% -$52 ﹤0.01% 6843
2022
Q4 		$0 Buy
+14
New +$99 ﹤0.01% 6663
2022
Q3 		– Sell
-477
Closed -$4K – 6557
2022
Q2 		$4K Sell
477
-515
-52% -$5.04K ﹤0.01% 6198
2022
Q1 		$13K Sell
992
-787
-44% -$10.6K ﹤0.01% 6160
2021
Q4 		$29K Sell
1,779
-15,814
-90% -$359K ﹤0.01% 6117
2021
Q3 		$464K Sell
17,593
-1,696
-9% -$49.5K ﹤0.01% 4777
2021
Q2 		$660K Sell
19,289
-723
-4% -$28.3K ﹤0.01% 4528
2021
Q1 		$1.01M Buy
20,012
+14,296
+250% +$885K ﹤0.01% 4218
2020
Q4 		$269K Buy
+5,716
New +$202K ﹤0.01% 4699
2020
Q3 		– Sell
-10,501
Closed -$105K – 5544
2020
Q2 		$105K Sell
10,501
-11,536
-52% -$125K ﹤0.01% 4548
2020
Q1 		$3.66M Hold
22,037
– – ﹤0.01% 2516
2019
Q4 		$335K Sell
22,037
-94
-0.4% -$1.41K ﹤0.01% 4446
2019
Q3 		$3.68M Hold
22,131
– – ﹤0.01% 2950
2019
Q2 		$3.68M Sell
22,131
-12,317
-36% -$228K ﹤0.01% 2889
2019
Q1 		$5.72M Hold
34,448
– – ﹤0.01% 2483
2018
Q4 		$682K Hold
34,448
– – ﹤0.01% 3970
2018
Q3 		$1.07M Buy
34,448
+1,234
+4% +$35.7K ﹤0.01% 3875
2018
Q2 		$5.52M Buy
33,214
+557
+2% +$17K ﹤0.01% 2614
2018
Q1 		$5.43M Hold
32,657
– – ﹤0.01% 2511
2017
Q4 		$1M Buy
32,657
+7,504
+30% +$295K ﹤0.01% 3732
2017
Q3 		$4.18M Buy
25,153
+610
+2% +$29.1K ﹤0.01% 2685
2017
Q2 		$4.08M Hold
24,543
– – ﹤0.01% 2602
2017
Q1 		$4.08M Buy
24,543
+8,543
+53% +$445K ﹤0.01% 2574
2016
Q4 		$816K Hold
16,000
– – ﹤0.01% 3532
2016
Q3 		$2.66M Hold
16,000
– – ﹤0.01% 2636
2016
Q2 		$2.66M Hold
16,000
– – ﹤0.01% 2658
2016
Q1 		$2.66M Buy
+16,000
New +$1.1M ﹤0.01% 2547
2015
Q3 		– Sell
-7,500
Closed -$663K – 3962
2015
Q2 		$663K Buy
7,500
+4,438
+145% +$430K ﹤0.01% 3468
2015
Q1 		$270K Sell
3,062
-419
-12% -$39.1K ﹤0.01% 3736
2014
Q4 		$321K Sell
3,481
-8,921
-72% -$945K ﹤0.01% 3841
2014
Q3 		$1.63M Sell
12,402
-7,944
-39% -$1.1M ﹤0.01% 3057
2014
Q2 		$3.33M Sell
20,346
-3,615
-15% -$622K ﹤0.01% 2277
2014
Q1 		$4.57M Buy
23,961
+16,371
+216% +$3.1M ﹤0.01% 2134
2013
Q4 		$1.49M Buy
+7,590
New +$1.4M ﹤0.01% 2941

Other funds holding EVGN

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

JP Morgan Chase's EVGN Position: Q2 2025 in Review

JP Morgan Chase sold out of Evogene (EVGN) in Q2 2025, closing a stake of 200 shares — an estimated $114 sold.

JP Morgan Chase first reported a position in EVGN in Q4 2013 and held it in 41 quarters. The position peaked at $5.72M in Q1 2019. 16 funds tracked by Wall St. Rank hold EVGN as of Q2 2025.

  • JP Morgan Chase reported no remaining Evogene position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 200 Evogene shares in Q2 2025, an estimated $114.
  • JP Morgan Chase first reported a position in Evogene in Q4 2013 and held it in 41 quarters.
  • JP Morgan Chase's Evogene position peaked at $5.72M in Q1 2019.
  • 16 funds tracked by Wall St. Rank held Evogene as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.